Showing results (221-230 of 267) with videos related to

Sort By:
Pageof 27
Diabetes|August 20, 2025
DNA Methylation Biomarkers Predict Offspring Metabolic Risk From Mothers With Hyperglycemia in PregnancyJohnny Assaf, Ishant Khurana, Ram Abou Zaki, et al.
Diabetologia|June 26, 2025
A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese populationJingyi Hu, Guozhi Jiang, Jiabi Qin, et al.
Neuro-Oncology|December 1, 2021
Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profilesMichael Zhang, Edward Wang, Derek Yecies, et al.
Diabetes Care|January 27, 2022
Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization AnalysisFeifei Cheng, Andrea O Luk, Mai Shi, et al.
Plos Medicine|July 30, 2020
Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes BiobankGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
Radiology|April 19, 2022
MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter StudyMichael Zhang, Samuel W Wong, Jason N Wright, et al.
Diabetes|January 19, 2022
Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 DiabetesGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2022
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes BiobankQiao Jin, Andrea O Luk, Eric S H Lau, et al.
Cardiovascular Diabetology|December 31, 2022
High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes BiobankQiao Jin, Eric S H Lau, Andrea O Luk, et al.
Diabetologia|November 12, 2024
Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetesGechang Yu, Claudia H T Tam, Cadmon K P Lim, et al.
Pageof 27